トップページ > 研究実績・活動実績 > 2021年度発表論文等一覧
2021年度発表論文等一覧
原著論文－英文
- Kawashima A, Kutsuna S, Shimomura A, Suzuki T, Nakamoto T, Ando H, Nagashima M, Inagaki T, Ohmagari N.
Catheter-related bloodstream infection caused by Tsukamurella ocularis: A case report.
J Infect Chemother. 2022 Mar;28(3):434-436. doi: 10.1016/j.jiac.2021.11.003. Epub 2021 Nov 18. PMID: 34802889. - Kawashima A, Kutsuna S, Shimomura A, Sato L, Ando H, Tanikawa T, Nagashima M, Miyoshi-Akiyama T, Inagaki T, Ohmagari N.
Streptobacillus notomytis Bacteremia after Exposure to Rat Feces.
Emerg Infect Dis. 2022 Apr;28(4):886-888. doi: 10.3201/eid2804.204965. PMID: 35318927; PMCID: PMC8962910. - Akiyama Y, Kinoshita N, Sadamasu K, Nagashima M, Yoshida I, Kusaba Y, Suzuki T, Nagashima M, Ishikane M, Takasaki J, Yoshimura K, Ohmagari N(2021).
“A pilot study of viral load in stools of patients with COVID-19 and diarrhea”.
Japanese Journal of Infectious Disseases. 2021 May 31.doi: 10.7883/yoken.JJID.2021.018. - Akiyama Y, Morioka S, Asai Y, Sato L, Suzuki S, Saito S, Matsunaga N, Hayakawa K, Ohmagari N.
Risk factors associated with asymptomatic hypoxemia among COVID-19 patients: a retrospective study using the nationwide Japanese registry, COVIREGI-JP.
J Infect Public Health. 2022 Jan 31;15(3):312-314. doi: 10.1016/j.jiph.2022.01.014. - Akiyama Y, Ishikane M, Ohmagari N (2021)
“Epstein-Barr virus induced skin rash in infectious mononucleosis”.
ID cases. 2021; 26: e01298. - Sho Saito, Kayoko Hayakawa, Ayako Mikami, Shinyu Izumi, Hideki Funazaki, Shinobu Ashida, Wataru Sugiura, Haruhito Sugiyama, Norihiro Kokudo, Norio Ohmagari.
Investigator initiated clinical trial of remdesivir for the treatment of COVID-19 in Japan.
Glob Health Med. 2021 Apr 30;3(2):62-66. - Nobumasa Okumura, Shinya Tsuzuki, Sho Saito, Tomoya Saito, Satoshi Takasago, Masayuki Hojo, Noriko Iwamoto, Norio Ohmagari.
The first eleven cases of SARS-CoV-2 Omicron variant infection in Japan: A focus on viral dynamics.
Glob Health Med. 2022;4(2):133-136. - Satoshi Kutsuna, Yusuke Asai, Akihiro Matsunaga, Noriko Kinoshita, Mari Terada, Yusuke Miyazato, Takato Nakamoto, Tetsuya Suzuki, Sho Saito, Mio Endo, Kohei Kanda, Kenji Maeda, Jin Takasaki, Masayuki Hojo, Yukihito Ishizaka, Norio Ohmagari.
Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19.
J Infect Chemother. 2021 Jun;27(6):808-813. - Mari Terada, Hiroshi Ohtsu, Sho Saito, Kayoko Hayakawa, Shinya Tsuzuki, Yusuke Asai, Nobuaki Matsunaga,Satoshi Kutsuna, Wataru Sugiura, Norio Ohmagari.
Risk factors for severity on admission and the disease progression during hospitalization in a large cohort of COVID-19 patients in Japan.
BMJ Open. 2021 Jun 15;11(6):e047007. - Andre C Kalil, Aneesh K Mehta, Thomas F Patterson, Nathaniel Erdmann, Carlos A Gomez, Mamta K Jain, Cameron R Wolfe, Guillermo M Ruiz-Palacios, Susan Kline, Justino Regalado Pineda, Anne F Luetkemeyer, Michelle S Harkins, Patrick E H Jackson, Nicole M Iovine, Victor F Tapson, Myoung-don Oh, Jennifer A Whitaker, Richard A Mularski, Catharine I Paules, Dilek Ince, Jin Takasaki, Daniel A Sweeney, Uriel Sandkovsky, David L Wyles, Elizabeth Hohmann, Kevin A Grimes, Robert Grossberg, Maryrose Laguio-Vila, Allison A Lambert, Diego Lopez de Castilla, EuSuk Kim, LuAnn Larson, Claire R Wan, Jessica J Traenkner, Philip O Ponce, Jan E Patterson, Paul A Goepfert, Theresa A Sofarelli, Satish Mocherla, Emily R Ko, Alfredo Ponce de Leon, Sarah B Doernberg, Robert L Atmar, Ryan C Maves, Fernando Dangond, Jennifer Ferreira, Michelle Green, Mat Makowski, Tyler Bonnett, Tatiana Beresnev, Varduhi Ghazaryan, Walla Dempsey, Seema U Nayak, Lori Dodd, Kay M Tomashek, John H Beigel, on behalf of the ACTT-3 study group members.
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial.
Lancet Respir Med. 2021 Oct 18;S2213-2600(21)00384-2. - Mark N. Polizzotto, Jacqueline Nordwall, Abdel G. Babiker, Andrew Phillips, David M. Vock, Nnakelu Eriobu, Vivian Kwaghe, Roger Paredes, Lourdes Mateu , Srikanth Ramachandruni, Rajeev Narang, Mamta K. Jain, Susana M. Lazarte, Jason V. Baker, Anne E.P. Frosch, Garyfallia Poulakou, Konstantinos N. Syrigos, Gretchen S. Arnoczy, Natalie A. McBride, Philip A. Robinson, Farjad Sarafian, Sanjay Bhagani, Hassan S. Taha, Thomas Benfield, Sean T.H. Liu, Anastasia Antoniadou, Jens Ulrik Stæhr Jensen, Ioannis Kalomenidis, Adityo Susilo, Prasetyo Hariadi, Tomas O. Jensen, Jose Luis Morales-Rull, Marie Helleberg, Sreenath Meegada, Isik S. Johansen, Daniel Canario, Eduardo Fernández-Cruz, Simeon Metallidis, Amish Shah, Aki Sakurai, Nikolaos G. Koulouris, Robin Trotman, Amy C. Weintrob, Daria Podlekareva, Usman Hadi, Kathryn M. Lloyd, Birgit Thorup Røge, Sho Saito, Kelly Sweerus, Jakob J. Malin, Christoph Lübbert, Jose Muñoz, Matthew J. Cummings, Marcelo H. Losso, Dan Turner, Kathryn Shaw-Saliba, Robin Dewar, Norman Gerry, Dona Arlinda, Christina C. Chang, Birgit Grund, Michael R. Holbrook, Horace P. Holley, Fleur Hudson, Laura A. McNay, Daniel D. Murray, Sarah L. Pett, Megan Shaughnessy, Mary C. Smolskis, Giota Touloumi, Mary E. Wright, Mittie K. Doyle, Sharon Popik, Christine Hall, Roshan Ramanathan, Huyen Cao, Elsa Mondou, Todd Willis, Joseph V. Thakuria, Leman Yel, Elizabeth Higgs, Virginia L. Kan, Jens D. Lundgren, James D. Neaton, H. Clifford Lane.
Hyperimmune Immunoglobulin for Hospitalized Patients With COVID-19.
Lancet. 2022 Feb 5;399(10324):530-540. - Tetsuya Suzuki, Satoshi Kutsuna, Sho Saito, Akira Kawashima, Ayako Okuhama, Kohei Kanda, Lubna Sato, Makoto Inada, Yutaro Akiyama, Satoshi Ide, Keiji Nakamura, Takato Nakamoto, Kei Yamamoto, Masahiro Ishikane, Noriko Kinoshita, Shinichiro Morioka, Kayoko Hayakawa, Norio Ohmagari.
Clinical course of alopecia after severe acute respiratory syndrome coronavirus 2 infection.
Int J Infect Dis. 2021 May 4;S1201-9712(21)00400-8. - Yumi Matsushita, Tetsuji Yokoyama, Kayoko Hayakawa, Nobuaki Matsunaga, Hiroshi Ohtsu, Sho Saito, Mari Terada, Setsuko Suzuki, Shinichiro Morioka, Satoshi Kutsuna, Tetsuya Mizoue, Hisao Hara, Akio Kimura, Norio Ohmagari.
Smoking, comorbidities, and severity of COVID-19 in hospitalized COVID-19 patients in Japan.
Int J Epidemiol. 2021 Dec 11:dyab254. - Satoshi Ide, Kayoko Hayakawa, Kei Yamamoto, Shinya Tsuzuki, Junko Tanuma, Kaori Ohara, Gen Yamada, Ayako Okuhama, Kohei Kanda, Tetsuya Suzuki, Yutaro Akiyama, Yusuke Miyazato, Keiji Nakamura, Hidetoshi Nomoto, Takato Nakamoto, Mugen Ujiie, Sho Saito, Shinichiro Morioka, Masahiro Ishikane, Noriko Kinoshita, Satoshi Kutsuna, Keiko Tanaka, Norio Ohmagari.
Positive ratio of polymerase chain reaction (PCR) and validity of pre-screening criteria at an outpatient screening center during the early phase of the COVID-19 epidemic in Japan.
Jpn J Infect Dis. 2021 Sep 22;74(5):481-486. - Mugen Ujiie, Shinya Tsuzuki, Michiyo Suzuki, Masayuki Ota, Tetsuya Suzuki, Hidetoshi Nomoto, Kei Yamamoto, Sho Saito, Akatsuki Kokaze, Noriko Kinoshita.
Safety of diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP) in adults in Japan.
Jpn J Infect Dis. 2021 Sep 22;74(5):399-404. - Hidetoshi Nomoto, Satoshi Kutsuna, Kazu Okuma, Madoka Kuramitsu, KentaTezuka, Emi Ikebe, Sho Saito, Noriko Kinoshita, Mari Terada, Mio Endo, Tetsuya Suzuki, Yusuke Miyazato, Takato Nakamoto, Makoto Inada, Isao Hamaguchi, Norio Ohmaga.
No SARS-CoV-2 RNA detection in the convalescent plasma of COVID-19 patients with different disease severity.
J Infect Chemother. 2021 Apr;27(4):653-655. - Gen Yamada, Kayoko Hayakawa, Yusuke Asai, Nobuaki Matsunaga, Hiroshi Ohtsu, Masayuki Hojo, Masao Hashimoto, Kentaro Kobayashi, Ryo Sasaki, Tatsuya Okamoto, Yasuaki Yanagawa, Daisuke Katagiri, Mari Terada, Michiyo Suzuki, Lubna Sato, Yusuke Miyazato, Masahiro Ishikane, Shinichiro Morioka, Sho Saito, Norio Ohmagari.
External Validation and Update of Prediction Models for Unfavorable Outcomes in Hospitalized Patients with COVID-19 in Japan.
J Infect Chemother. 2021 Jul;27(7):1043-1050. - Mari Terada, Satoshi Kutsuna, Tomiteru Togano, Sho Saito, Noriko Kinoshita, Yumiko Shimanishi, Tetsuya Suzuki, Yusuke Miyazato, Makoto Inada, Takahito Nakamoto, Hidetoshi Nomoto, Satoshi Ide, Mitsuhiro Sato, Kenji Maeda, Akihiro Matsunaga, Masahiro Satake, Keiji Matsubayashi, Hirokazu Tsuno, Makiko Kojima, Madoka Kuramistu, Kenta Tezuka, Emi Ikebe, Kazu Okuma, Isao Hamaguchi, Katsuyuki Shiratori, Motohiko Sato, Yuiko Kawakami, Kumi Inaba, Saori Igarashi, Reina Yamauchi, Mina Matsumura, Keiko Ishimaru, Bijuan Zhang, Chika Kuge, Maiko Ishihara, Miho Gouda, Keiko Tanaka, Yukihito Ishizaka, Norio Ohmagari.
How we secured a COVID-19 Convalescent Plasma Procurement Scheme in Japan.
Transfusion. 2021 Jul;61(7):1998-2007. - Gen Yamada, Kayoko Hayakawa, Nobuaki Matsunaga, Mari Terada, Setsuko Suzuki, Yusuke Asai, Hiroshi Ohtsu, Ako Toyoda, Koji Kitajima, Shinya Tsuzuki, Sho Saito, Norio Ohmagari.
Predicting respiratory failure for COVID-19 patients in Japan: a simple clinical score for evaluating the need for hospitalization.
Epidemiol Infect. 2021; 149: e175. - Ayako Okuhama, Masatoshi Hotta, Masahiro Ishikane, Akira Kawashima, Yusuke Miyazato, Mari Terada, Gen Yamada, Kohei Kanda, Makoto Inada, Lubna Sato, Mitsuhiro Sato, Yutaro Akiyama, Tetsuya Suzuki, Takato Nakamoto, Hidetoshi Nomoto, Satoshi Ide, Keiji Nakamura, Sho Saito, Noriko Kinoshita, Kei Yamamoto, Shinichiro Morioka, Mugen Ujiie, Kayoko Hayakawa, Satoshi Kustuna, Yoshitaka Shida, Tsuyoshi Tajima, Katsuji Teruya, Yumi Funato, Makiko Yamamoto, Shinyu Izumi, Masayuki Hojo, Haruhito Sugiyama, Norio Ohmagari.
Fatty liver on computed tomography scan on admission is a risk factor for severe coronavirus disease.
J Infect Chemother. 2022 Feb;28(2):217-223. - Tetsuya Suzuki, Yusuke Asai, Satoshi Ide, Saori Fukuda, Akihito Tanaka, Yumiko Shimanishi, Kozue Takahashi, Mari Terada, Lubna Sato, Mitsuhiro Sato, Makoto Inada, Gen Yamada, Yusuke Miyazato, Yutaro Akiyama, Hidetoshi Nomoto, Takato Nakamoto, Keiji Nakamura, Tomiteru Togano, Shinichiro Morioka, Noriko Kinoshita-Iwamoto, Sho Saito, Satoshi Kutsuna, Norio Ohmagari.
Factors associated with high antibody titer following coronavirus disease among 581 convalescent plasma donors: A single-center cross-sectional study in Japan.
J Infect Chemother. Feb;28(2):206-210. 2022 - Satoshi Ide, Sho Saito, Tsubasa kazawa, Takahito Furuya, Junichi Masuda, , Maki Nagashima, , Yusuke Asai, , Tatsunori Ogawa, , Ryohei Yamamoto, Haruhiko Ishioka, , Kohei Kanda, , Ayako Okuhama, , Yuji Wakimoto, Tetsuya Suzuki, Yutaro Akiyama, , Yusuke Miyazato, , Keiji Nakamura, , Takato Nakamoto, , Hidetoshi Nomoto, Yuki Moriyama, Masayuki Ota, Shinichiro Morioka, , Wataru Matsuda, , Tatsuki Uemura, Kentaro Kobayashi, , Ryo Sasaki, Daisuke Katagiri, , Satoshi Kutsuna, , Kayoko Hayakawa, , Norio Ohmagari.
Extracorporeal membrane oxygenation may decrease the plasma concentration of remdesivir in a patient with severe coronavirus disease 2019.
IDCases. 2021 Nov 17;26:e01343. - Yusuke Asai, Hidetoshi Nomoto, Kayoko Hayakawa, Nobuaki Matsunaga, Shinya Tsuzuki, Mari Terada, Hiroshi Ohtsu, Koji Kitajima, Kumiko Suzuki, Tetsuya Suzuki, Keiji Nakamura, Shinichiro Morioka, Sho Saito, Fumitake Saito, Norio Ohmagari.
Comorbidities as Risk Factors for Severe Disease in Hospitalized Elderly COVID-19 Patients by Different Age Groups in Japan.
Gerontology. 2022 Jan 7;1-11. - Shinya Tsuzuki, Kayoko Hayakawa, Yukari Uemura, Tomohiro Shinozaki, Nobuaki Matsunaga, Mari Terada, Setsuko Suzuki, Yusuke Asai, Koji Kitajima, Sho Saito, Gen Yamada, Taro Shibata, Masashi Kondo, Kazuo Izumi, Masayuki Hojo, Tetsuya Mizoue, Kazuhisa Yokota, Fukumi Nakamura-Uchiyama, Fumitake Saito, Wataru Sugiura, Norio Ohmagari.
Effectiveness of remdesivir in hospitalized nonsevere patients with COVID-19 in Japan: A large observational study using the COVID-19 Registry Japan.
Int J Infect Dis. 2022 Feb 19;118:119-125. - Michiyo Suzuki, Kayoko Hayakawa, Yusuke Asai, Nobuaki Matsunaga, Mari Terada, Hiroshi Ohtsu, Ako Toyoda, Jin Takasaki, Masayuki Hojo, Yasuaki Yanagawa, Sho Saito, Kei Yamamoto, Satoshi Ide, Yutaro Akiyama, Tetsuya Suzuki, Ataru Moriya, Kazuhisa Mezaki, Norio Ohmagari.
Evaluation of the detection of other pathogens in hospitalized patients with COVID-19 at a tertiary hospital in Japan.
Jpn J Infect Dis. 2022 Feb 28. - Shinya Tsuzuki, Kayoko Hayakawa, Yohei Doi, Tomohiro Shinozaki, Yukari Uemura, Nobuaki Matsunaga, Mari Terada, Setsuko Suzuki, Yusuke Asai, Gen Yamada, Sho Saito, Taro Shibata, Masashi Kondo, Kazuo Izumi, Masayuki Hojo, Tetsuya Mizoue, Kazuhisa Yokota, Fukumi Nakamura-Uchiyama, Fumitake Saito, Wataru Sugiura, Norio Ohmagari.
Effectiveness of Favipiravir on Nonsevere, Early-Stage COVID-19 in Japan: A Large Observational Study Using the COVID-19 Registry Japan.
Infect Dis Ther. 2022 Mar 21;1-13. - Mikako Ueno, Naoko Iwata-Yoshikawa, Akihito Matsunaga, Tadashi Okamura, Sho Saito, Shinobu Ashida, Isao Yoshida, Mami Nagashima, Hiroyuki Asakura, Yuu I. Yaoita, Jun Suzuki, Kenji Sadamasu, Kazuhisa Yoshimura, Satoshi Kutsuna, Nozomi Shiwa-Sudo, Noriyo Nagata, Tadaki Suzuki, Akinori Suzuki, Miwa Okamoto, Moto Kimura, Norio Ohmagari, Ryu Miura, Yukihito Ishizaka.
Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variant.
Antiviral Res. 2022 Mar 24;105297. - Shoji K, Tsuzuki S, Akiyama T, Matsunaga N, Asai Y, Suzuki S, Iwamoto N, Funaki T, Yamada M, Ozawa N, Yamaguchi K, Miyairi I, Ohmagari N.
Clinical characteristics and outcomes of COVID-19 in pregnant women: a propensity score matched analysis of the data from the COVID-19 Registry Japan.
Clin Infect Dis. 2022 Jan 17:ciac028. - Maruki T, Iwamoto N, Kanda K, Okumura N, Yamada G, Ishikane M, Ujiie M, Saito M, Fujimoto T, Kageyama T, Saito T, Saito S, Suzuki T, Ohmagari N.
Two cases of breakthrough SARS-CoV-2 infections caused by the Omicron variant (B.1.1.529 lineage) in international travelers to Japan.
Clin Infect Dis. 2022 Jan 3:ciab1072. - Shoji K, Akiyama T, Tsuzuki S, Matsunaga N, Asai Y, Suzuki S, Iwamoto N, Funaki T, Ohmagari N.
Clinical Characteristics of Hospitalized COVID-19 in Children: Report From the COVID-19 Registry in Japan.
J Pediatric Infect Dis Soc. 2021 Sep 6:piab085. - Okubo Y, Nishi A, Michels KB, Nariai H, Kim-Farley RJ, Arah OA, Uda K, Kinoshita N, Miyairi I.
The consequence of financial incentives for not prescribing antibiotics: a Japan's nationwide quasi-experiment.
Int J Epidemiol. 2022 Mar 30:dyac057. - Takashita E, Kinoshita N, Yamayoshi S, Sakai-Tagawa Y, Fujisaki S, Ito M, Iwatsuki-Horimoto K, Halfmann P, Watanabe S, Maeda K, Imai M, Mitsuya H, Ohmagari N, Takeda M, Hasegawa H, Kawaoka Y.
Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2.
N Engl J Med. 2022 Apr 14;386(15):1475-1477. - Takashita E, Kinoshita N, Yamayoshi S, Sakai-Tagawa Y, Fujisaki S, Ito M, Iwatsuki-Horimoto K, Chiba S, Halfmann P, Nagai H, Saito M, Adachi E, Sullivan D, Pekosz A, Watanabe S, Maeda K, Imai M, Yotsuyanagi H, Mitsuya H, Ohmagari N, Takeda M, Hasegawa H, Kawaoka Y.
Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant.
N Engl J Med. 2022 Mar 10;386(10):995-998. - Nomoto H, Yamamoto K, Yamada G, Suzuki M, Kinoshita N, Takasaki J, Moriya A, Maeda K, Kimura M, Ohmagari N.
Time-course evaluation of the quantitative antigen test for severe acute respiratory syndrome coronavirus 2: The potential contribution to alleviating isolation of COVID-19 patients.
J Infect Chemother. 2021 Nov;27(11):1669-1673. - Okubo Y, Nariai H, Michels KB, Kim-Farley RJ, Nishi A, Arah OA, Kinoshita N, Uda K, Miyairi I.
Change in clinical practice variations for antibiotic prescriptions across different pediatric clinics: A Japan's nationwide observational study.
J Infect Chemother. 2021 Nov;27(11):1621-1625. - Ujiie M, Tsuzuki S, Nakamoto T, Iwamoto N.
Resurgence of Respiratory Syncytial Virus Infections during COVID-19 Pandemic, Tokyo, Japan.
Emerg Infect Dis. 2021 Nov;27(11):2969-2970. - Togano T, Uemura Y, Asai Y, Hayakawa K, Matsunaga N, Terada M, Ohtsu H, Suzuki S, Toyoda A, Hara H, Sato R, Ishikane M, Kinoshita-Iwamoto N, Hangaishi A, Ohmagari N.
The influence of pre-admission antiplatelet and anticoagulation therapy on the illness severity in hospitalized patients with COVID-19 in Japan.
J Infect Chemother. 2021 Oct;27(10):1498-1503. - Yamamoto K, Suzuki M, Yamada G, Sudo T, Nomoto H, Kinoshita N, Nakamura K, Tsujimoto Y, Kusaba Y, Morita C, Moriya A, Maeda K, Yagi S, Kimura M, Ohmagari N.
Corrigendum to "Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission"[Int J Infect Dis 104 (2021) 65-72].
Int J Infect Dis. 2021 Aug;109:323. - Yamamoto K, Nagashima M, Yoshida I, Sadamasu K, Kurokawa M, Nagashima M, Kinoshita N, Maeda K, Takasaki J, Teruya K, Ohmagari N.
Does the SARS-CoV-2 rapid antigen test result correlate with the viral culture result?
J Infect Chemother. 2021 Aug;27(8):1273-1275. - Inada M, Ishikane M, Terada M, Matsunaga A, Maeda K, Tsuchiya K, Miura K, Sairenji Y, Kinoshita N, Ujiie M, Kutsuna S, Ishizaka Y, Mitsuya H, Ohmagari N.
Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of neutralizing antibodies.
J Infect Chemother. 2021 Jul;27(7):1063-1067. - Anzurez A, Naka I, Miki S, Nakayama-Hosoya K, Isshiki M, Watanabe Y, Nakamura-Hoshi M, Seki S, Matsumura T, Takano T, Onodera T, Adachi Y, Moriyama S, Terahara K, Tachikawa N, Yoshimura Y, Sasaki H, Horiuchi H, Miyata N, Miyazaki K, Koga M, Ikeuchi K, Nagai H, Saito M, Adachi E, Yotsuyanagi H, Kutsuna S, Kawashima A, Miyazato Y, Kinoshita N, Kouno C, Tanaka K, Takahashi Y, Suzuki T, Matano T, Ohashi J, Kawana-Tachikawa A.
Association of HLA-DRB1*09:01 with severe COVID-19.
HLA. 2021 Jul;98(1):37-42. - Nishida T, Iwahashi H, Yamauchi K, Kinoshita N, Okauchi Y, Suzuki N, Inada M, Abe K.
Seroprevalence of SARS-CoV-2 antibodies among 925 staff members in an urban hospital accepting COVID-19 patients in Osaka prefecture, Japan: A cross-sectional study.
Medicine (Baltimore). 2021 Jun 25;100(25):e26433. - Suzuki T, Kutsuna S, Saito S, Kawashima A, Okuhama A, Kanda K, Sato L, Inada M, Akiyama Y, Ide S, Nakamura K, Nakamoto T, Yamamoto K, Ishikane M, Kinoshita N, Morioka S, Hayakawa K, Ohmagari N.
Clinical course of alopecia after COVID-19.
Int J Infect Dis. 2021 Jun;107:255-256. - Katagiri D, Ishikane M, Asai Y, Izumi S, Takasaki J, Katsuoka H, Kondo I, Ide S, Nakamura K, Nakamoto T, Nomoto H, Akiyama Y, Miyazato Y, Suzuki T, Kinoshita N, Ogawa T, Togano T, Suzuki M, Hashimoto M, Sakamoto K, Kusaba Y, Katsuno T, Fukaya T, Hojo M, Sugiyama M, Mizokami M, Okamoto T, Kimura A, Noiri E, Ohmagari N, Hinoshita F, Sugiyama H.
Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19.
J Clin Apher. 2021 Jun;36(3):313-321. - Ogawa T, Uemura T, Matsuda W, Sato M, Ishizuka K, Fukaya T, Kinoshita N, Nakamoto T, Ohmagari N, Katano H, Suzuki T, Hosaka S.
SARS-CoV-2 Leakage From the Gas Outlet Port During Extracorporeal Membrane Oxygenation for COVID-19.
ASAIO J. 2021 May 1;67(5):511-516. - Khor SS, Omae Y, Nishida N, Sugiyama M, Kinoshita N, Suzuki T, Suzuki M, Suzuki S, Izumi S, Hojo M, Ohmagari N, Mizokami M, Tokunaga K.
HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure.
Front Immunol.2021 Apr 22;12:658570. - Kanda K, Kinoshita N, Kutsuna S, Nakamura K, Okuhama A, Shimomura A, Inagaki T, Yoshikawa T, Kurosu T, Shimojima M, Saijo M, Ohmagari N.
Residual and Late Onset Symptoms Appeared in a Patient with Severe Fever with Thrombocytopenia in a Convalescence Stage.
Viruses. 2021 Apr 10;13(4):657. - Takano T, Matsumura T, Adachi Y, Terahara K, Moriyama S, Onodera T, Nishiyama A, Kawana-Tachikawa A, Miki S, Hosoya-Nakayama K, Nakamura-Hoshi M, Seki S, Tachikawa N, Yoshimura Y, Miyata N, Horiuchi H, Sasaki H, Miyazaki K, Kinoshita N, Sudo T, Akiyama Y, Sato R, Suzuki T, Matano T, Takahashi Y.
Myeloid cell dynamics correlating with clinical outcomes of severe COVID-19 in Japan.
Int Immunol. 2021 Mar 31;33(4):241-247. - Maeda K, Higashi-Kuwata N, Kinoshita N, Kutsuna S, Tsuchiya K, Hattori SI, Matsuda K, Takamatsu Y, Gatanaga H, Oka S, Sugiyama H, Ohmagari N, Mitsuya H.
Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma.
Sci Rep. 2021 Mar 10;11(1):5563. - Yamamoto K, Asai Y, Nakatani I, Hayashi K, Nakagawa H, Shinohara K, Kanai S, Shimatani M, Yamato M, Shimono N, Kitaura T, Komiya N, Nagasaka A, Mikawa T, Manabe A, Matono T, Yamamoto Y, Ogawa T, Kutsuna S, Ohmagari N.
Characteristics and potential quality indicators for evaluating pre-travel consultations in Japan hospitals: the Japan Pretravel consultation registry (J-PRECOR).
Trop Dis Travel Med Vaccines. 2022 Feb 1; 8(1):6. doi: 10.1186/s40794-021-00160-4. PMID: 35101123; PMCID: PMC8805374. - Motohashi A, Yamamoto K, Mezaki K, Moriya A, Kurokawa M, Oki H, Ando H, Isaka E, Usami A, Ide S, Nakamura K, Nakamoto T, Nomoto H, Ohmagari N.
Negative Results of Nucleic Acid Amplification Tests for SARS-CoV-2 in Clinical Practice May Vary among Six Molecular Assays in Patients with COVID-19.
Jpn J Infect Dis. 2022 May 24;75(3):309-313. doi: 10.7883/yoken.JJID.2021.416. Epub 2021 Sep 30. PMID: 34588366. - Yamamoto K, Mezaki K, Ohmagari N.
Simple indictor of increased blood culture contamination rate by detection of coagulase-negative staphylococci.
Sci Rep. 2021 Sep 2;11(1):17538. doi: 10.1038/s41598-021-96997-y. PMID: 34475478; PMCID: PMC8413347. - Inada M, Ishikane M, Terada M, Matsunaga A, Maeda K, Iwamoto N, Ujiie M, Kutsuna S, Morioka S, Ishizaka Y, Mitsuya H, Ohmagari N.
Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection.
Int J Infect Dis. 2022 Mar 16:S1201-9712(22)00155-2. doi: 10.1016/j.ijid.2022.03.017. Epub ahead of print. PMID: 35306204; PMCID: PMC8925083. - Ono A, Koizumi R, Tsuzuki S, Asai Y, Ishikane M, Kusama Y, Ohmagari N.
Antimicrobial Use Fell Substantially in Japan in 2020-The COVID-19 Pandemic May Have Played a Role.
Int J Infect Dis. 2022 Mar 16:S1201-9712(22)00157-6. doi: 10.1016/j.ijid.2022.03.019. Epub ahead of print. PMID: 35306203; PMCID: PMC8926437. - Takahashi K, Ishikane M, Ujiie M, Iwamoto N, Okumura N, Sato T, Nagashima M, Moriya A, Suzuki M, Hojo M, Kanno T, Saito S, Miyamoto S, Ainai A, Tobiume M, Arashiro T, Fujimoto T, Saito T, Yamato M, Suzuki T, Ohmagari N.
Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees.
Emerg Infect Dis. 2022 Mar 15;28(5). doi: 10.3201/eid2805.220197. Epub ahead of print. PMID: 35290176. - Beppu H, Ogawa T, Ishikane M, Kawanishi T, Fukuda T, Sato L, Matsunaga A, Maeda K, Katagiri D, Ishizaka Y, Mitsuya H, Ohmagari N, Yasui F, Kohara M, Kikuchi K, Wakai S.
A case of COVID-19 reinfection in a hemodialysis patient: the role of antibody in SARS-CoV-2 infection.
CEN Case Rep. 2022 Mar 9:1–6. doi: 10.1007/s13730-022-00697-z. Epub ahead of print. PMID: 35266095; PMCID: PMC8906520. - Ishikane M, Kubota H, Moriya A, Kutsuna S, Ando H, Kaburagi Y, Suzuki T, Iwamoto N, Kimura M, Ohmagari N.
Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, a Rapid Multiplex PCR Method for the Diagnosis of COVID-19.
J Infect Chemother. 2022. Available online 9 February - Miyazato Y, Yamamoto K, Yamada G, Kubota S, Ishikane M, Sugiyama M, Ueno M, Matsunaga A, Miyoshi-Akiyama T, Ishizaka Y, Ohmagari N.
Multisystem Inflammatory Syndrome in Adult after First Dose of mRNA Vaccine.
Emerg Infect Dis. 2022 Feb 11;28(4). doi: 10.3201/eid2804.212585. Epub ahead of print. PMID: 35148495. - Suzuki T, Morioka S, Nomoto H, Takaya S, Ishikane M, Yanagisawa S, Hayakawa K, Ohmagari N.
Disseminated Streptococcus anginosus invasive infection with intracranial subdural abscess formation.
J Infect Chemother. 2022 Jan 9:S1341-321X(21)00352-4. doi: 10.1016/j.jiac.2021.12.016. Epub ahead of print. PMID: 35016822. - Inose R, Muraki Y, Kamimoto Y, Kusama Y, Koizumi R, Yamasaki D, Ishikane M, Tanabe M, Ohmagari N.
The intended purpose and regional patterns of use of antibiotics for managing Clostridioides (Clostridium) difficile infections: An analysis of the National Database of Health Insurance Claims and Specific Health Checkups data of Japan.
J Infect Chemother. 2022 Feb;28(2):356-358. doi: 10.1016/j.jiac.2021.12.004. Epub 2021 Dec 13. PMID: 34916136. - Nomoto H, Ishikane M, Lee S, Komiya N, Maeki T, Matsui T, Morita K, Oshitani H, Saijo M, Yamagishi T, Yamamoto T, Ohmagari N.
Facilitating the deployment of Japanese human resources for responding global outbreaks of emerging and Re-emerging infectious diseases: A cross-sectional study.
J Infect Chemother. 2022 Jan;28(1):41-46. doi: 10.1016/j.jiac.2021.09.015. Epub 2021 Oct 8. PMID: 34635449. - Nakanishi T, Inose R, Kusama Y, Ishikane M, Kajihara T, Yahara K, Sugai M, Ohge H, Ohmagari N, Muraki Y.
The Use of Topical Antibiotics Based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) Open Data in 2017.
Jpn J Infect Dis. 2022 Mar 24;75(2):177-182. doi: 10.7883/yoken.JJID.2021.450. Epub 2021 Sep 30. PMID: 34588368. - Banno M, Tsujimoto Y, Ishikane M.
Need for More Randomized Controlled Trials With Rigorous Methodology to Confirm That Ivermectin Is Not a Viable Option for the Treatment of Coronavirus Disease 2019.
Clin Infect Dis. 2022 Mar 23;74(6):1121-1122. doi: 10.1093/cid/ciab689. PMID: 34358296; PMCID: PMC8385944. - Akiyama Y, Kinoshita N, Sadamasu K, Nagashima M, Yoshida I, Kusaba Y, Suzuki T, Nagashima M, Ishikane M, Takasaki J, Yoshimura K, Ohmagari N.
A Pilot Study on Viral Load in Stool Samples of Patients with COVID-19 Suffering from Diarrhea.
Jpn J Infect Dis. 2022 Jan 24;75(1):36-40. doi: 10.7883/yoken.JJID.2021.018. Epub 2021 May 31. PMID: 34053956. - Nakanishi T, Inose R, Kusama Y, Ishikane M, Kajihara T, Yahara K, Sugai M, Ohge H, Ohmagari N, Muraki Y.
The use of topical antibiotics based on National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) Open Data in 2017.
Jpn J Infect Dis. 2021 Sep 30. doi: 10.7883/yoken.JJID.2021.450. Epub ahead of print. PMID: 34588368. - Maruki T, Ishikane M, Suzuki T, Ujiie M, Katano H, Ohmagari N.
A case of varicella zoster virus meningitis following BNT162b2 mRNA COVID-19 vaccination in an immunocompetent patient.
Int J Infect Dis. 2021 Sep 26;113:55-57. doi: 10.1016/j.ijid.2021.09.055. Epub ahead of print. PMID: 34587536; PMCID: PMC8467371. - Hikida S, Morioka S, Fujii N, Tajima T, Terayama Y, Sugiura Y, Ishikane M, Takasaki J, Hojo M, Ohmagari N.
A single-center descriptive study of untraced sources of infection among new cases of coronavirus disease in Tokyo, Japan.
Glob Health Med. 2021 Aug 31;3(4):236-239. doi: 10.35772/ghm.2021.01092. PMID: 34532604; PMCID: PMC8403258. - Okuhama A, Ishikane M, Hotta M, Sato L, Akiyama Y, Morioka S, Suzuki S, Tajima T, Yamamoto M, Teruya K, Izumi S, Ohmagari N.
Clinical and radiological findings of silent hypoxia among COVID-19 patients.
J Infect Chemother. 2021 Oct;27(10):1536-1538. doi: 10.1016/j.jiac.2021.07.002. Epub 2021 Jul 8. PMID: 34294527; PMCID: PMC8264520. - Ebisui A, Inose R, Kusama Y, Koizumi R, Kawabe A, Ishii S, Goto R, Ishikane M, Yagi T, Ohmagari N, Muraki Y.
Trends in Antipseudomonal Agent Use Based on the 2006 to 2015 Sales Data in Japan.
Biol Pharm Bull. 2021;44(6):816-821. doi: 10.1248/bpb.b21-00004. PMID: 34078813. - Ide S, Ishikane M, Ohmagari N.
Antimicrobials-induced esophageal ulcer.
IDCases. 2021 Apr 17;24:e01128. doi: 10.1016/j.idcr.2021.e01128. PMID: 33981580; PMCID: PMC8085691. - Kusama Y, Muraki Y, Tanaka C, Koizumi R, Ishikane M, Yamasaki D, Tanabe M, Ohmagari N.
Characteristics and limitations of national antimicrobial surveillance according to sales and claims data.
PLoS One. 2021 May 11;16(5):e0251299. doi: 10.1371/journal.pone.0251299. PMID: 33974635; PMCID: PMC8112693. - Fujita M, Umeda T, Fujita N, Nishioka T, Iwamoto A, Ohmagari N, Ishikane M, Akashi H, Kokudo N.
Japanese WHO Collaborating Centres (WHO CCs) fight against COVID-19.
Glob Health Med. 2021 Apr 30;3(2):115-118. doi: 10.35772/ghm.2020.01093. PMID: 33937576; PMCID: PMC8071681. - Ide S, Ishikane M, Ohmagari N.
Posterior auricular lymphadenopathy in adult rubella.
IDCases. 2021 Mar 30;24:e01093. doi: 10.1016/j.idcr.2021.e01093. PMID: 33898252; PMCID: PMC8056234. - Moriyama Y, Ishikane M, Kusama Y, Matsunaga N, Tajima T, Hayakawa K, Ohmagari N.
Nationwide cross-sectional study of antimicrobial stewardship and antifungal stewardship programs in inpatient settings in Japan.
BMC Infect Dis. 2021 Apr 16;21(1):355. doi: 10.1186/s12879-021-06035-5. PMID: 33858346; PMCID: PMC8050890. - Hamada Y, Kasai H, Suzuki-Ito M, Matsumura Y, Doi Y, Hayakawa K.
Pharmacokinetic/Pharmacodynamic Analysis and Dose Optimization of Cefmetazole and Flomoxef against Extended-Spectrum β-Lactamase-Producing Enterobacterales in Patients with Invasive Urinary Tract Infection Considering Renal Function.
Antibiotics (Basel). 2022 Mar 28;11(4):456. - Matsunaga N, Hayakawa K, Asai Y, Tsuzuki S, Terada M, Suzuki S, Ohtsu H, Kitajima K, Toyoda A, Suzuki K, Suzuki M, Saito S, Uemura Y, Shibata T, Kondo M, Nakamura-Uchiyama F, Yokota K, Saito F, Izumi K, Sugiura W, Ohmagari N.
Clinical characteristics of the first three waves of hospitalised patients with COVID-19 in Japan prior to the widespread use of vaccination: a nationwide observational study.
Lancet Reg Health West Pac. 2022 Mar 16;22:100421. - Hiroi Y, Ohtsu H, Uemura Y, Hayakawa K, Asai Y, Kutsuna S, Terada M, Sugiura W, Ohmagari N.
Cardiovascular Complications of Hospitalized Patients With Coronavirus Disease 2019 in a Japanese Registry in 2020.
Circ J. 2022 Feb 25;86(3):464-471. - Suzuki T, Morioka S, Nomoto H, Takaya S, Ishikane M, Yanagisawa S, Hayakawa K, Ohmagari N.
Disseminated Streptococcus anginosus invasive infection with intracranial subdural abscess formation.
J Infect Chemother. 2022 May;28(5):696-698. - Nomoto H, Suzuki S, Asai Y, Hayakawa K, Gatanaga H, Terada M, Suzuki K, Ohtsu H, Toyoda A, Ohmagari N.
Clinical characteristics and prognosis of immunosuppressed inpatients with COVID-19 in Japan.
J Infect Chemother. 2022 Feb;28(2):224-231. - Hamada Y, Matsumura Y, Nagashima M, Akazawa T, Doi Y, Hayakawa K.
Retrospective evaluation of appropriate dosing of cefmetazole for invasive urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli.
J Infect Chemother. 2021;27(11):1602-1606. - Ide S, Kutsuna S, Yamada G, Hashimoto K, Abe M, Nagi M, Ujiie M, Hayakawa K, Ohmagari N.
Pulmonary histoplasmosis diagnosed in a Japanese woman after traveling to central and South America: A case report.
J Infect Chemother. 2021;27(11):1658-1661. - Tajima T, Asai Y, Endo M, Suzuki T, Matsunaga N, Tsuzuki S, Hayakawa K, Ohmagari N.
Rate of blood culture submissions in Japan as an indicator of bloodstream infections.
J Infect Chemother. 2021;27(8):1270-1272. - Yamamoto N, Koizumi Y, Tsuzuki S, Ejima K, Takano M, Iwami S, Mizushima D, Oka S.
Evaluating the cost-effectiveness of a pre-exposure prophylaxis program for HIV prevention for men who have sex with men in Japan.
Sci Rep . 2022 Feb 23;12(1):3088. doi: 10.1038/s41598-022-07116-4. - Ujiie M, Kitano T, Tsuzuki S.
Changing trends in HPV vaccination in Japan.
Hum Vaccin Immunother. 2021 Oct 7:1-3. doi: 10.1080/21645515.2021.1986333. - Iwanami S, Ejima K, Kim KS, Noshita K, Fujita Y, Miyazaki T, Kohno S, Miyazaki Y, Morimoto S, Nakaoka S, Koizumi Y, Asai Y, Aihara K, Watashi K, Thompson RN, Shibuya K, Fujiu K, Perelson AS, Iwami S, Wakita T.
Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study.
PLoS Med. 2021 Jul 6;18(7):e1003660. doi: 10.1371/journal.pmed.1003660. - Ide S, Hayama H, Asai Y, Terada M, Nomoto H, Kutsuna S, Ohmagari N, Hiroi Y.
Evaluation of high-sensitivity cardiac troponin T levels in Japanese patients recently recovered from Coronavirus disease 2019.
Circulation Journal. 2021 May 25;85(6):944-947. doi: 10.1253/circj.CJ-21-0219. - Ono A, Aoyagi K, Muraki Y, Asai Y, Tsuzuki S, Koizumi R, Azuma T, Kusama Y, Ohmagari N.
Trends in healthcare visits and antimicrobial prescriptions for acute infectious diarrhea in individuals aged 65 years or younger in Japan from 2013 to 2018 based on administrative claims database: a retrospective observational study.
BMC Infect Dis. 2021 Sep 21;21(1):983. doi: 10.1186/s12879-021-06688-2. - Tsuzuki S, Jiefu Y, Matsunaga N, Ohmagari N.
Length of stay, hospitalisation cost and in-hospital mortality of methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia in Japan.
Public Health. 2021 Sep 7;198:292-296. doi: 10.1016/j.puhe.2021.07.046. - Tsuzuki S, Matsunaga N, Yahara K, Shibayama K, Sugai M, Ohmagari N.
Disease burden of bloodstream infections caused by antimicrobial resistant bacteria: a population-level study—Japan, 2015-2018.
Int J Infect Dis. 2021 May 13;108:119-124. doi: 10.1016/j.ijid.2021.05.018. - Morioka S, Gu Y, Tsuzuki S, Fujitomo Y, Soeda H, Nakahama C, Hasegawa N, Maesaki S, Maeda M, Matsumoto T, Miyairi I, Ohmagari N.
Determinants of clinic doctors’ attitudes concerning antimicrobial prescription for patients with common colds or bronchitis: additional analysis of a nationwide survey conducted by the Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases.
J Infect Chemother. 2021 Feb;27(2):131-138. doi: 10.1016/j.jiac.2020.11.017. - Kutsuna S, Asai Y, Yamamoto K, Shirano M, Konishi K, Asaoka T, Yamato M, Katsuragi Y, Yamamoto Y, Sahara T, Tamiya A, Nakamura-Uchiyama F, Sakamoto N, Kosaka A, Washino T, Hase R, Mito H, Kuraita T, Shinohara K, Shimizu T, Kodama F, Nagasaka A, Ogawa T, Kasahara K, Yoshimura Y, Tachikawa N, Yokota K, Murai NSY, Sakamaki I, Hasegawa C, Yoshimi Y, Toyoda K, Mitsuhashi T, Ohmagari N.
Epidemiogogical trends of imported infectious disease in Japan: Aanlysis of imported 2-year infectious disease registry data.
J Infect Chemother. 2021 Apr;27(4):632-638. doi: 10.1016/j.jiac.2020.11.028. - Koizumi R, Kusama Y, Asai Y, Gu Y, Muraki Y, Ohmagari N.
Effects of the cefazolin shortage on the sales, cost, and appropriate use of other antimicrobials.
BMC Health Serv Res. 2021 Oct 19;21(1):1118. doi: 10.1186/s12913-021-07139-z. - Yoshiaki Gu, Yumiko Fujitomo, Rie Takahashi, Norio Ohmagari.
Japan's first online media seminar on antimicrobial resistance.
GHM Open Volume 1. Tokyo. 2021. Issue 1(36-37) - Yoshiaki Gu, Yumiko Fujitomo, Norio Ohmagari.
Outcomes and Future Prospect of Japan's National Action Plan on Antimicrobial Resistance (2016-2020).
Antibiotics (Basel). 2021 Oct 22;10(11):1293. - Miyazato Y, Tsuzuki S, Morioka S, Terada M, Kutsuna S, Saito S, Shimanishi Y, Takahashi K, Sanada M, Akashi M, Kuge C, Osanai Y, Tanaka K, Suzuki M, Hayakawa K, Ohmagari N.
Factors associated with development and persistence of post-COVID conditions: A cross-sectional study.
Journal of Infection and Chemotherapy. In press in April 2022. - Matsunaga A, Tsuzuki S, Morioka S, Ohmagari N, Ishizuka Y.
Long COVID: current status in Japan and knowledge about its molecular background.
Globan Health and Medicine. 2022;4(2):83-93. - Morioka S, Tan BH, Kikuchi H, Asai Y, Suzuki T, Ashida S, Kutsuna S, Saito S, Hayakawa K, Tan TT, Ohmagari N.
Factors Associated With Prolonged Psychological Distress Among Nurses and Physicians Engaged in COVID-19 Patient Care in Singapore and Japan.
Frontiers in Psychiatry 13:781796. doi: 10.3389/fpsyt.2022.781796. - Morioka S, Kurosu H, Kutsuna S, Sato M, Kunimitsu T, Koshiba M, Ohmagari N.
Building an effective infection prevention and control system in Japan: a historical review. Institutional Repository for Information Sharing.
World Health Organization. In press in June, 2021. - Yamamoto S, Fukunaga A, Tanaka A, Takeuchi J, Inoue Y, Kimura M, Maeda K, Ueda G, Mizoue T, Ujiie M, Sugiura W, Shagari N.
Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine.
Vaccine. 2022;40:1924-1927. - Ujiie M.
Deaths due to dengue in Japanese travellers.
J Travel Med. 2021 Jul 7;28(5):taab076. - Fujino T, Nomoto H, Kutsuna S, Ujiie M, Suzuki T, Sato R, Fujimoto T, Kuroda M, Wakita T, Ohmagari N.
Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan.
Emerg Infect Dis. 2021 Apr;27(4):1243-1245. - Butler MS, Gigante V, Sati H, Paulin S, Al-Sulaiman L, Rex JH, Fernandes P,Arias CA, Paul M, Thwaites GE, Czaplewski L, Alm RA, Lienhardt C, Spigelman M,Silver LL, Ohmagari N, Kozlov R, Harbarth S, Beyer P.
Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is Needed.
Antimicrob Agents Chemother. 2022 Mar15;66(3):e0199121. - Morita C, Suzuki M, Izumi S, Tsukada A, Tsujimoto Y, Sakamoto K, Hashimoto M,Takasaki J, Ohmagari N, Hojo M.
Clinical outcomes of corticosteroids for COVID-19 patients at the National Center for Global Health and Medicine during the first wave of infections.
Respir Investig. 2022 Mar;60(2):241-247. - Kawamoto Y, Kaku N, Akamatsu N, Sakamoto K, Kosai K, Morinaga Y, Ohmagari N, Izumikawa K, Yamamoto Y, Mikamo H, Kaku M, Oishi K, Yanagihara K.
The surveillance of colistin resistance and mobilized colistin resistance genes in multidrug-resistant Enterobacteriaceae isolated in Japan.
Int J Antimicrob Agents. 2022 Jan;59(1):106480. - Simmons B, Ariyoshi K, Ohmagari N, Pulcini C, Huttner B, Gandra S, Satta G, Moja L, Sharland M, Magrini N, Miraldo M, Cooke G.
Progress towards antibiotic use targets in eight high-income countries.
Bull World Health Organ. 2021 Aug 1;99(8):550-561. - Imai M, Halfmann PJ, Yamayoshi S, Iwatsuki-Horimoto K, Chiba S, Watanabe T, Nakajima N, Ito M, Kuroda M, Kiso M, Maemura T, Takahashi K, Loeber S, Hatta M, Koga M, Nagai H, Yamamoto S, Saito M, Adachi E, Akasaka O, Nakamura M, Nakachi I, Ogura T, Baba R, Fujita K, Ochi J, Mitamura K, Kato H, Nakajima H, Yagi K, Hattori SI, Maeda K, Suzuki T, Miyazato Y, Valdez R, Gherasim C, Furusawa Y, Okuda M, Ujie M, Lopes TJS, Yasuhara A, Ueki H, Sakai-Tagawa Y, Eisfeld AJ, Baczenas JJ, Baker DA, O'Connor SL, O'Connor DH, Fukushi S, Fujimoto T, Kuroda Y, Gordon A, Maeda K, Ohmagari N, Sugaya N, Yotsuyanagi H, Mitsuya H, Suzuki T,Kawaoka Y.
Characterization of a new SARS-CoV-2 variant that emerged in Brazil.
Proc Natl Acad Sci U S A. 2021 Jul 6;118(27):e2106535118. - Nangaku M, Kadowaki T, Yotsuyanagi H, Ohmagari N, Egi M, Sasaki J, Sakamoto , Hasegawa Y, Ogura T, Chiba S, Node K, Suzuki R, Yamaguchi Y, Murashima A, Ikeda N, Morishita E, Yuzawa K, Moriuchi H, Hayakawa S, Nishi D, Irisawa A, Miyamoto T, Suzuki H, Sone H, Fujino Y.
The Japanese Medical Science Federation COVID-19 Expert Opinion English Version.
JMA J. 2021 Apr 15;4(2):148-162. - Hashimoto T, Shiojiri D, Ohmagari N.
A Retrospective Study of the Optimal Number of Blood Cultures at a Hospital in Japan.
Tohoku J Exp Med. 2021 Apr;253(4):233-239. - Rodríguez-Baño J, Rossolini GM, Schultsz C, Tacconelli E, Murthy S, Ohmagari N, Holmes A, Bachmann T, Goossens H, Canton R, Roberts AP, Henriques-Normark B, Clancy CJ, Huttner B, Fagerstedt P, Lahiri S, Kaushic C, Hoffman SJ, Warren M, Zoubiane G, Essack S, Laxminarayan R, Plant L.
Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance.
Trans R Soc Trop Med Hyg. 2021 Oct 1;115(10):1122-1129. - Miki T, Yamamoto S, Inoue Y, Fukunaga A, Islam Z, Ishiwari H, Ishii M, Miyo K, Konishi M, Ohmagari N, Mizoue T.
Association between living with others and depressive symptoms in Japanese hospital workers during the COVID-19 pandemic.
Psychiatry Clin Neurosci. 2021 Apr;75(4):148-149. - Kamata K, Jindai K, Ide K, Funaki T, Saito H, Takeshita N, Ohmagari N, Hinoshita E, Asanuma K.
The Flight Evacuation Mission for COVID-19 from Wuhan, China to Tokyo, Japan from January 28 to February 17, 2020.
Jpn J Infect Dis. 2021 Jul 21;74(4):373-376. - Nishida N, Sugiyama M, Kawai Y, Naka I, Iwamoto N, Suzuki T, Suzuki M, Miyazato Y, Suzuki S, Izumi S, Hojo M, Tsuchiura T, Ishikawa M, Ohashi J, Ohmagari N, Tokunaga K, Mizokami M.
Genetic association of IL17 and the importance of ABO blood group antigens in saliva to COVID-19.
Sci Rep. 2022 Mar 9;12(1):3854. - Yamamoto S, Mizoue T, Tanaka A, Oshiro Y, Inamura N, Konishi M, Ozeki M, Miyo K, Sugiura W, Sugiyama H, Ohmagari N.
Sex-associated differences between BMI and SARS-CoV-2 antibody titers following the BNT162b2 vaccine.
Obesity (Silver Spring). 2022 May;30(5):999-1003. - Miki T, Yamamoto S, Fukunaga A, Inoue Y, Ishiwari H, Ishii M, Miyo K, Konishi M, Ohmagari N, Mizoue T.
Association between eating balanced meals and depressive symptoms in Japanese hospital workers during the COVID-19 pandemic.
Neuropsychopharmacol Rep. 2022 Mar;42(1):109-113. - Chujo D, Kurokawa T, Kawabe A, Takahashi N, Inagaki F, Shinohara K, Hagiwara S, Edamoto Y, Ohmagari N, Hinoshita F, Tajima T, Kajio H, Ohtsu H, Takemura N, Matsumoto S, Shimoda M.
Allogeneic islet transplantation with monitoring of islet-specific cellular autoimmunity in a Japanese patient with type 1 diabetes: A case report.
J Diabetes Investig. 2022 Apr;13(4):741-745. - Lee S, Ishizuka A, Tachimori H, Uechi M, Akashi H, Hinoshita E, et al.
Japan's development cooperation for health in Vietnam: a first holistic assessment on Japan's ODA and non-ODA public resources cooperation.
BMC public health. 2021;21(1):2175.
原著論文－和文
- 山元佳、氏家無限、鈴木哲也、井手聡、守山祐樹、太田雅之、齋藤 翔、早川佳代子、大曲貴夫.
渡航前相談における成人の麻疹・風疹・ムンプス・水痘抗体検査がキャッチアップ接種に与える影響.
感染症学雑誌. 2021 Vol.95 No.5. - 古山 千晶, 野々垣 彰, 杉森 彩香, 田中 弘子, 加藤 和夏, 小原 明希, 青笹 尚彦, 玉木 毅, 山田 玄, 木下 典子.
外傷後に生じた顔面皮膚ノカルジア症の1例
日本皮膚科学会雑誌(0021-499X)131巻9号 Page2096-2097(2021.08) - 堀米 顕久, 渥美 ゆかり, 瓜生 英子, 高砂 聡志, 水上 愛弓, 木下 典子, 赤松 智久, 田中 瑞恵, 山中 純子, 五石 圭司, 七野 浩之.
左下腿蜂窩織炎の治療中に発症したリウマチ熱の1例.
小児科臨床(0021-518X)74巻9号 Page1087-1091(2021.09) - 田中知佳*, 日馬由貴, 村木優一, 石金正裕,早川佳代子,大曲貴夫.
2018 年における病院薬剤師を対象とした抗菌薬使用量サーベイランスの現状把握調査.
日本化学療法学会雑誌. V69 (5): 376-382, 2021. - 田口 真帆, 森岡 慎一郎*, 石金 正裕, 片浪 雄一, 忽那 賢志, 大曲 貴夫.
日本内科学会雑誌 (0021-5384)110巻8号 Page1681-1684(2021.08) - 小泉龍士*, 日馬由貴, 石金正裕, 田中知佳, 大野茜子, 具芳明, 金子明寛, 大曲貴夫.
自己記入式アンケートを用いた歯科医師の外来診療における抗菌薬処方実態を明らかにするための横断研究.
日本感染症学会雑誌. 2021 年 95 巻 2 号 p. 122-128 - 海外入院歴のある渡航者のmedical evacuationで多剤耐性微生物が検出されたが入院時のスクリーニングより感染拡大を来さなかった2例.
井手 聡, 木下 典子, 野本 英俊, 中村 啓二, 太田 雅之, 目崎 和久, 中村 茂樹, 宮崎 義継, 忽那 賢志, 早川 佳代子, 大曲 貴夫.
感染症学雑誌 (0387-5911)95巻2号 Page141-146(2021.03) - 大野茜子、日馬由貴、佐藤匡博、小泉龍士、岩元典子、大曲貴夫.
診療所における抗菌薬適正使用支援のための抗菌薬処方モニタリングシステム開発に向けた調査研究、
日本プライマリ・ケア連合学会誌、2022年45巻1号p. 25-30 - 李 祥任, 明石 雅子, 宮原 麗子, 草場 勇作, 森田 直美, 堀 成美, 高崎 仁.
医療通訳者の感染予防と安全な労働環境の検討 -雇用・組織・社会的観点から-.
国際臨床医学会雑誌 5(1) 66-72 (2021. 12) - 李 祥任, 明石 雅子, 宮原 麗子, 森田 直美, 草場 勇作, 堀 成美, 高崎 仁.
医療通訳者の感染予防に関する全国調査：新型コロナウイルス感染症を含む感染症対応におけるニーズと課題、感染予防策の実態.
日本渡航医学会誌.15(2) 83-93 (2021.9)
口頭・ポスター発表－国際学会・研究会
- Sho Saito, et al.
Distribution and associated mortality in carbapenem-resistant gram-negative bacilli in Japan: A multicenter study from Multi-Drug Resistant organisms
clinical research network (MDRnet), 2021 IDweek, (poster) - Kei Yamamoto.
Diagnostic Performance and Clinical Significance of Clinical Tests: COVID-19 Diagnostic Algorithm, The 12th NCGM International Infectious Diseases Forum, June 7, 2021. - GOARN派遣帰国報告会第3回オンラインセミナー（パプワニューギニア） (2022年3月, Web)
- WHO. BioHub Consultation (2022年3月, Web)
- GOARN. Global Meeting of Partners 2021. (2021年12月, Web)
- Cases of Adverse Events of COVID-19 Vaccination. Ad-hoc Panel of MIRE on COVID-19. (2021年11月, Web)
- Koizumi R, Ishikane M, Kusama Y, Tsuzuki S, Asai Y, Shimada Y, Tanaka C, Ohno A, Kaneko A, Ohmagari N.
National Cross-Sectional Study of Factors Influencing the Decision of Prescribing Penicillin as First Choice among Dentists in Japan.
IDWeek2021 (Virtual. Oct 2021) (Poster) - Morioka S.
A overview of Long-COVID research in Japan.
(Oral presentation in the CRN North Thames Long-COVID National Landscape Webinar on February 16, 2022.) - Morioka S.
Challenges and difficulties in COVID-19 patient care, and necessary approaches in palliative care.
(Oral presentation at the 14th Asia Pacific Hospice Conference 2021, Kobe, Japan on November 13th, 2021.) - Suzuki K.
Prevalence of healthcare-associated infections and antimicrobial use in "Ryoyo" wards, stratified long-term care beds in Japanese long-term care facilitiese: a point prevalence survey .
ECCMID2021(2021.7)(Poster) - Tsuzuki S.
Length of stay, hospitalisation cost, and in-hospital fatalities from methicillin-susceptible and -resistant Staphylococcus aureus bacteraemia in a Japanese tertiary care hospital
ECCMID2021(2021.7) - Koizumi R, Kusama Y, Asai Y, Gu Y, Muraki Y, Ohmagari N.
Impact of a Nationwide Cefazolin Shortage on Antimicrobial Supply in Japan.
ECCMID 2021, Austria (On Web) - Ono A., Aoyagi K., Muraki, Y., Asai, Y., Tsuzuki S., Koizumi R., Azuma T., Kusama Y., & Ohmagari N. (2021).
Trends in healthcare visits and antimicrobial prescriptions for acute infectious diarrhea in individuals aged 65 years or younger in Japan from 2013 to 2018 based on administrative claims database: a retrospective observational study.
ECCMID 2021, Austria (On Web) - Koizumi R, Ishikane M, Kusama Y, Tsuzuki S, Asai Y, Shimada Y, Tanaka C, Ono A, Kaneko A, Ohmagari N.
National Cross-Sectional Study of the Factors on Decision Making of Penicillin Prescription as First Choice among Dentists in Japan.
IDWEEK2021 (OnWeb)
口頭・ポスター発表－国内学会・研究会
- 川島亮、忽那賢志、長島麻希、佐藤ルブナ、谷川力、稲垣剛志、大曲貴夫
ねずみの糞便の吸入・経口感染で発症したと考えられるStreptobacillusnotomytisによる鼠咬症の一例
第95回日本感染症学会学術講演会 - 川島亮、忽那賢志、長島麻希、鈴木哲也、中本貴人、稲垣剛志、大曲貴夫
Tsukamurella ocularisによるカテーテル関連血流感染症の一例
第70回日本感染症学会東日本地方会学術集会 - 齋藤翔, 他
口腔内から全身につながる感染症と耐性菌
第75回日本口腔科学会学術集会, 2021年5月 - 齋藤翔.
院内感染症診断支援ツール開発に向けたAIモデルの構築
第41回医療情報学連合大会, 2021年11月 - 齋藤翔, 他.
本邦におけるカルバペネム耐性EnterobacteralesおよびAeromonas spp感染/保菌例の薬剤感受性: Multi-Drug Resistant organisms clinical research network (MDRnet) による多施設共同研究
第33回日本臨床微生物学会総会・学術集会, 2022年1月 - 齋藤翔, 他.
本邦におけるカルバペネム耐性Pseudomonas aeruginosaおよびStenotrophomonas maltophilia感染/保菌例の薬剤感受性: Multi-Drug Resistant organisms clinical research network (MDRnet)による多施設共同研究
第33回日本臨床微生物学会総会・学術集会, 2022年1月 - 栂野富輝、半下石明、齋藤翔、忽那賢志、大曲貴夫.
日本におけるCCP療法
第69回日本輸血・細胞治療学会学術総会, 2021年6月 - 佐々木 健, 稲田 誠, 岩元 典子, 大曲 貴夫
ショックと右膝関節痛を来したYersinia enterocolitica菌血症の高齢女性例
日本内科学会関東地方会674回 Page40(2021.12) - 山元佳ら
グラム染色像を用いて早期に菌種推定を行う画像AIの研究開発
日本臨床微生物学会学術集会、2022/1/29 - 山元佳
シンポジウム2 新型コロナウイルス 感染症の診断法の新知見「各種検査の臨床活用」
第95回日本感染症学会学術講演会・第69回日本化学療法学会総会 合同学会、2021/5/7 - 山元佳
新型コロナ禍の小児の海外渡航に関わる感染症の予防
第6回かがわ小児感染症研究会、2021/6/25 - 齋藤智也, 中瀬克己, 中里栄介, 長谷川麻衣子, 石金正裕, 大曲貴夫.
脆弱性評価ガイダンスを活用したピアレビュー方式による対応能力評価の実装.
第35回公衆衛生情報研究協議会総会・研究(2022年1月, Web) - 石金正裕.
感染症疫学の基本.
感染症レビューコース (2021年11月, Web） - 石金正裕.
新型コロナウイルス感染症の診断・治療.
IDATEN オンラインセミナー2021（2021年11月, Web） - 石金正裕.
Letter to the editorの書き方をデザインする:観察研究編.
日本臨床疫学会 第4回年次学術大会（2021年10月, Web） - 小泉龍士, 佐藤匡博, 日馬由貴, 青柳健介, 村木優一, 田中知佳, 大野茜, 石金正裕, 岩元典子, 大曲貴夫.
医療リアルワールドデータ研究に必須の抗微生物薬データベースの開発.
日本臨床疫学会 第4回年次学術大会（2021年10月, Web） - 稲田誠, 石金正裕, 早川佳代子, 大曲貴夫.
Leptospira interrogans serogroup Hebdomadisによる菌血症を起こした1例.
第70回日本感染症学会東日本地方会学術集会（2021年10月, 東京) - 片山由梨,片桐大輔,石金正裕,寺川可那子,嶋田啓基,坂本絵美,新倉崇仁,山田玄,目崎和久,黒川正美,常彬,吉崎幸,鈴木みなみ,高野秀樹.
Streptococcus oralisによる敗血症,腎盂腎炎の一例.
日本腎臓学会東日本地方会（2021年9月, 東京） - 石金正裕.
薬局薬剤師がとるべき新型コロナウイルス感染症の感染対策.
2021年度スキルアップ講座 (2021年6月, 東京） - 石金正裕.
その抗菌薬は本当に必要?
2021年度スキルアップ講座 (2021年6月, 東京） - 野本英俊, 石金正裕, 古宮伸洋, 森田公一, 押谷仁, 西條政幸, 山岸拓也, 大曲貴夫.
日本からの国際感染症危機対応への派遣促進因子に関するアンケート調査.
第95回日本感染症学会総会・学術講演会 (2021年4月, 東京) - 宮里悠佑, 石金正裕, 安田満, 大曲貴夫.
多剤耐性Mycoplasma genitaliumによる尿道炎をスペクチノマイシン,ドキシサイクリン併用で加療した一例.
第95回日本感染症学会総会・学術講演会 (2021年4月, 東京) - 田島太一
（ポスター）
第9回日本感染管理ネットワーク学会・学術集会（web開催） - 鈴木久美子
特別養護老人ホームにおける感染症診療体制および抗菌薬使用状況調査－Point Prevalence Survey－
第36回日本環境感染学会、愛知県、2021年9月 - 坂口みきよ
手指消毒使用量サーベイランス方法の実態－J-SIPHE参加施設への調査
第36回日本環境感染学会、愛知県、2021年9月 - 坂口みきよ
手指消毒使用量サーベイランスにおける使用量と払い出し量との関係
第36回日本環境感染学会、愛知県、2021年9月 - 遠藤美緒、都築慎也、浅井雄介、田島太一、坂口みきよ、藤井直樹、松永展明、早川佳代子、大曲貴夫
感染対策連携共通プラットフォーム（J-SIPHE）における 2019 年注射抗菌薬の感染防止対策加算別使用状況の報告
第31回日本医療薬学会（WEB開催）、2021年10月 - 大黒幸恵、川名三知代、大山かがり、江藤不二子、三浦哲也、赤羽三貴、遠藤美緒、石川洋一
小児薬物療法研究会で行った薬剤耐性（AMR）資材配布企画が地域薬剤師に与えた影響の調査研究 ～薬局薬剤師の意識や行動変容の考察～
第48回日本小児臨床薬理学会（ハイブリッド開催）、2021年10月 - 遠藤美緒、川名三知代、鈴木康大、川下晃代、中井啓、小村誠、石川洋一
地域薬剤師による薬剤耐性（AMR）普及啓発活動のための課題の調査研究：より参加しやすい資材配布企画へ向けた考察
第48回日本小児臨床薬理学会（ハイブリッド開催）、2021年10月（最優秀ポスター賞受賞） - 鈴木久美子
特別養護老人ホームにおける感染管理体制-Point Prevalence Survey
第80回日本公衆衛生学会総会（WEB開催）、2021年12月 - 藤友結実子, 具芳明, 大曲貴夫
20-30歳代の抗菌薬の捉え方・受療行動に関する調査
第70回日本感染症学会東日本地方会学術集会 第68回日本化学療法学会東日本支部総会 合同学会、2021年10月、東京. - 氏家無限.
新型コロナウイルスワクチン接種に係る研修.
新宿区主催 医療機関医師に向けた新型コロナウイルスワクチン接種に係る研修. 2021年4月 - 氏家無限.
今できるCOVID-19の診療と展望.
CareNet.com 診療よろず相談TV. 2021年4月 - 氏家無限.
「低・中所得国のコロナ対策でなぜいま検査が必要か, COVID 19 収束に向けた3つの医療手段「検査、治療、ワクチン」の資源分配を考える.
日本国際交流センター メディア向けブリーフィング 2021年6月 - 氏家無限.
途上国でのコロナワクチン接種の開始に際して、国際協力NGOとして押さえておくべきワクチンの情報.
GII/IDI懇談会NGO連絡会 新型コロナと援助に関する意見交換会. 2021年6月 - 氏家無限.
日本における予防接種・ワクチン政策の課題とコロナ禍.
日本医療政策機構 予防接種・ワクチン政策推進プロジェクト 国会議員向け勉強会 2021年6月 - 氏家無限.
COVID-19の現状と院内感染対策.
令和3年度第1回北信ICT連絡協議会合同カンファレンス. 2021年7月 - 氏家無限.
新型コロナウイルス感染症流行下における海外渡航者に求められる入国要件と課題.
BMSA 第39回トラベラーズワクチン研修会. 2021年10月 - 氏家無限.
新型コロナウイルスワクチン接種に関する各論.
中東協力センター 中東情勢/実務セミナー. 2021年10月 - 氏家無限.
ワクチン接種の考え方.
2022 ドラベ症候群患者家族会. 2022年1月 - 氏家無限.
予防接種・ワクチン政策の前進と振り返りに求められる情報とは.
日本政策医療機構 予防接種・ワクチン政策推進プロジェクト専門家会合. 2022年2月 - 李祥任, 河津里沙, 内村和広, 大角晃弘.
地域ブロック別外国出生肺結核患者に関する治療成績、患者の背景因子の検討: 結核登録者情報システムのデータ活用分析.
第96回日本結核・非結核性抗酸菌症学会総会・学術講演会, 6月18-19日, 2021. WEB開催.(口頭) - 李祥任、草場勇作、高崎仁.
新型コロナウイルス感染症・結核等の感染症対応における医療通訳方法のニーズ: 医療通訳者の全国実態調査より.
第96回日本結核・非結核性抗酸菌症学会総会・学術講演会, 6月18-19日, 2021. WEB開催. (口頭) - 李祥任, 座間智子,大角晃弘, 加藤誠也.
在住ベトナム人を対象にした結核・COVID-19リスクコミュニケーションの質的検討.
第80回日本公衆衛生学会総会, 12月21-23日, 2021. 東京. (口頭) - 李祥任.
SNSによる地域を超えたアプローチ-結核・COVID-19リスクコミュニケーションのためのベトナムコミュニティーとの連携-.
第10回日本公衆衛生看護学会学術集会.ワークショップ, 口頭発表(2022.1.)
著書・総説
単行本－和文
- 亀谷航平, 齋藤翔.
重症度別治療法概説, COVID-19と腎臓病, 腎と透析
東京医学者, 2022年1月 - 岩元典子, 宇田和宏.
地域の薬局を巻き込んだ抗菌薬適正使用
内科(0022-1961)129巻2号 Page285-287(2022.02) - 岩元典子
予防接種を必要とする成人 基礎疾患を持つ人 無脾症
Medicina(0025-7699)59巻3号 Page454-457(2022.03) - 石金正裕.
新型コロナウイルスに対する抗ウイルス薬の効果について【わが国では2021年10月時点で、レムデシビルのみが認証されている。適応は入院を要する患者で、酸素投与が必要な症例に可及的速やかに投与することで、臨床症状の改善に効果がある可能性が示唆されている】(Q&A).
日本医事新報 (0385-9215)5098号 Page50-51(2022.01) - 石金正裕.
HEALTH RULES (ヘルス・ルールズ) 病気のリスクを劇的に下げる健康習慣. (分担：新型コロナウイルス感染症とかぜ・インフルエンザ）
集英社 2022年1月 - 石金正裕.
雑誌「腎と透析」(分担：新型コロナウイルス感染症の易感染・重症化リスク因子).
東京医学社 2022年1月 - 石金正裕.
感染症別 出席・出勤停止期間ガイド～新型コロナウイルス感染症中心に（電子コンテンツ）.
日本医事新報社 2021年11月 - 石金正裕.
医師が語る処方箋の裏側.急性膀胱炎にレボフロキサシンではなくST合剤を処方する理由
日経ドラッグインフォメーション. Page 004 (2021. 09) - 石金正裕.
マスギャザリングと懸念される感染症90
KANSEN JOURNAL（2021. 10. 05） - 石金正裕.
【新型コロナウイルス感染症による血栓に対する治療について教えてください。抗凝固薬は使用可能でしょうか？】
インフルエンザ (1345-8345)22巻2号 Page54-55(2021.06) - 石金正裕.
【その考えはもう古い!-最新・感染症診療】診断・治療の最新の考え方 治療薬・治療法再考 治療期間について考え直す 菌血症,骨髄炎(解説/特集).
Medicina (0025-7699)58巻5号 Page614-618(2021.04)